Reed Smith's Life Sciences Health Industry Group will be hosting an upcoming CLE webinar, "The Good, the Bad and the Ugly: The Best and Worst Drug/Medical Device Decisions of 2018" on Wednesday, January 16, 2019 at 12 p.m. ET.
Each year since 2007, Reed Smith's Drug and Device Law blog contributors have compiled and posted lists of the 10 best and 10 worst drug and medical device court decisions for that year. Starting with their 2013 lists, the bloggers have followed up with a webinar discussing these decisions. These cases are selected based on their likely precedential value, their importance to drug and device manufacturers, and their inherent (and subjective) merit.
In this webinar, our litigators who blog for Drug and Device Law will explain the significance – whether good or bad – of each case and provide insight into how the cases will likely be influential in the future.
This program is presumptively approved for 1.5 general CLE credit in California, Illinois, New Jersey, Pennsylvania, Texas and West Virginia. For lawyers licensed in New York, this course is eligible for 1.5 credit under New York's Approved Jurisdiction Policy.
You can register by clicking here.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.